re: Ann: USA FDA Grants Orphan Drug Status fo... FDA like it and why wouldn't they?
From the last investor presentation.
7 out of 9 patients responded positively to drugs that they had previously been resistant to. (i.e PAT-SM6 makes cancer cells more sensitive to other drugs)
Ann: USA FDA Grants Orphan Drug Status for PAT-SM, page-2
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1031795 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1050244 | 4 |
View Market Depth
| Last trade - 11.06am 21/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable